Schnieders Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.17M Buy
9,070
+1,010
+13% +$118K 0.15% 91
2026
Q1
$969K Buy
8,060
+434
+6% +$50.1K 0.15% 91
2025
Q4
$803K Buy
7,626
+500
+7% +$46.9K 0.13% 95
2025
Q3
$598K Sell
7,126
-1,767
-20% -$146K 0.11% 116
2025
Q2
$704K Sell
8,893
-4,157
-32% -$330K 0.12% 106
2025
Q1
$1.17M Sell
13,050
-3,028
-19% -$283K 0.25% 70
2024
Q4
$1.6M Sell
16,078
-5,489
-25% -$566K 0.32% 53
2024
Q3
$2.45M Sell
21,567
-4,034
-16% -$479K 0.47% 45
2024
Q2
$3.17M Sell
25,601
-7,874
-24% -$1.01M 0.64% 36
2024
Q1
$4.42M Sell
33,475
-216
-0.6% -$26.6K 0.91% 30
2023
Q4
$3.67M Sell
33,691
-4,394
-12% -$456K 0.81% 31
2023
Q3
$3.92M Buy
38,085
+174
+0.5% +$18.8K 0.88% 29
2023
Q2
$4.37M Buy
37,911
+91
+0.2% +$10.3K 0.91% 27
2023
Q1
$4.02M Buy
37,820
+51
+0.1% +$5.51K 0.9% 32
2022
Q4
$4.19M Buy
37,769
+125
+0.3% +$12.8K 0.96% 31
2022
Q3
$3.24M Buy
37,644
+7,550
+25% +$674K 0.86% 33
2022
Q2
$2.74M Buy
30,094
+186
+0.6% +$16.5K 0.82% 36
2022
Q1
$2.45M Sell
29,908
-902
-3% -$71.1K 0.58% 48
2021
Q4
$2.36M Sell
30,810
-437
-1% -$34.8K 0.55% 49
2021
Q3
$2.35M Buy
31,247
+4,392
+16% +$334K 0.63% 41
2021
Q2
$2.09M Sell
26,855
-442
-2% -$32.9K 0.57% 44
2021
Q1
$2.01M Buy
27,297
+4,992
+22% +$368K 0.6% 42
2020
Q4
$1.74M Buy
22,305
+2,909
+15% +$222K 0.57% 47
2020
Q3
$1.53M Buy
19,396
+7,762
+67% +$608K 0.58% 43
2020
Q2
$858K Buy
11,634
+499
+4% +$37.6K 0.34% 61
2020
Q1
$818K Buy
11,135
+362
+3% +$28.4K 0.39% 60
2019
Q4
$935K Buy
10,773
+1,100
+11% +$90.3K 0.34% 75
2019
Q3
$777K Sell
9,673
-1,441
-13% -$115K 0.31% 78
2019
Q2
$889K Buy
11,114
+1,048
+10% +$80.2K 0.35% 76
2019
Q1
$798K Buy
10,066
+32
+0.3% +$2.39K 0.34% 74
2018
Q4
$731K Hold
10,034
0.36% 72
2018
Q3
$679K Sell
10,034
-1,121
-10% -$71.4K 0.28% 84
2018
Q2
$646K Sell
11,155
-840
-7% -$47.4K 0.27% 86
2018
Q1
$624K Sell
11,995
-5,421
-31% -$293K 0.27% 88
2017
Q4
$935K Sell
17,416
-13,997
-45% -$776K 0.39% 71
2017
Q3
$1.92M Buy
31,413
+131
+0.4% +$7.94K 0.84% 46
2017
Q2
$1.91M Buy
31,282
+5,528
+21% +$337K 0.89% 38
2017
Q1
$1.56M Buy
25,754
+1,572
+7% +$95.4K 0.75% 46
2016
Q4
$1.36M Buy
24,182
+4,606
+24% +$270K 0.7% 48
2016
Q3
$1.17M Buy
19,576
+5,633
+40% +$329K 0.65% 52
2016
Q2
$766K Hold
13,943
0.43% 75
2016
Q1
$704K Sell
13,943
-2,358
-14% -$115K 0.42% 72
2015
Q4
$822K Sell
16,301
-640
-4% -$32.3K 0.51% 63
2015
Q3
$798K Buy
16,941
+576
+4% +$30.6K 0.55% 60
2015
Q2
$889K Sell
16,365
-209
-1% -$11.7K 0.52% 59
2015
Q1
$909K Buy
16,574
+1,231
+8% +$69.7K 0.55% 58
2014
Q4
$831K Buy
15,343
+1,991
+15% +$111K 0.55% 59
2014
Q3
$755K Sell
13,352
-1,048
-7% -$58.8K 0.56% 56
2014
Q2
$795K Buy
14,400
+3,878
+37% +$212K 0.56% 52
2014
Q1
$570K Buy
10,522
+629
+6% +$32.6K 0.53% 61
2013
Q4
$472K Buy
+9,893
New +$452K 0.46% 68

Other funds holding MRK

Schnieders Capital Management's MRK Position: Q2 2026 in Review

Schnieders Capital Management increased its Merck (MRK) stake by 13% in Q2 2026, buying an estimated $118K and bringing the position to 9,070 shares worth $1.17M. The position accounts for 0.15% of the portfolio, ranked #91.

Schnieders Capital Management first reported a position in MRK in Q4 2013 and has held it in 51 quarters since. The position peaked at $4.42M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Schnieders Capital Management held 9,070 shares of Merck worth $1.17M as of Q2 2026.
  • Schnieders Capital Management bought 1,010 Merck shares in Q2 2026, an estimated $118K.
  • Merck made up 0.15% of Schnieders Capital Management's portfolio in Q2 2026, its #91 holding.
  • Schnieders Capital Management first reported a position in Merck in Q4 2013 and has held it in 51 quarters since.
  • Schnieders Capital Management's Merck position peaked at $4.42M in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Schnieders Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.